• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
    All News #Library
    Biotech

    AEON Biopharma Sets Annual Shareholder Meeting

    FIRSTWORD PHARMA

    AEON Bio Gets Further NYSE American Listing Notice

    GLOBENEWSWIRE

    AEON Bio Reports Inducement Grants Per NYSE American Guide

    GLOBENEWSWIRE

    AEON Biopharma Reports 2025 Results and Positive ABP-450 Data

    GLOBENEWSWIRE

    AEON Bio Receives FDA Feedback On ABP-450 Biosimilar Program

    GLOBENEWSWIRE

    AEON Biopharma Abstract Accepted for AAN 2026 Presentation

    GLOBENEWSWIRE

    AEON Biopharma Holds FDA Meeting on BPD Type 2A

    GLOBENEWSWIRE

    AEON Bio Reports Inducement Grants Per NYSE American LLC Guide

    GLOBENEWSWIRE

    AEON Bio: First PIPE Investment Close, FDA Type 2A Meeting Update

    GLOBENEWSWIRE

    AEON Biopharma Confirms Identical Amino Acid Sequences

    GLOBENEWSWIRE

    Aeon Bio To Hold FDA Bpd Type 2a Meeting For Abp-450 On Nov 19

    GLOBENEWSWIRE

    AEON Biopharma Q2 2025 Financial Results and Corporate Update

    GLOBENEWSWIRE

    Aeon Biopharma Reports Q1 2025 Financials and Corporate Update

    GLOBENEWSWIRE

    AEON Biopharma Reports Q4 and Full Year 2024 Results

    GLOBENEWSWIRE

    Aeon Bio Receives Notice of Non-Compliance with NYSE American

    GLOBENEWSWIRE

    Aeon Biopharma Closes $20.0M Underwritten Public Offering

    GLOBENEWSWIRE

    Aeon Biopharma`s Prices $20.0M of Underwritten Public Offering

    GLOBENEWSWIRE

    AEON Biopharma Announces Launch of Proposed Public Offering

    GLOBENEWSWIRE

    AEON Biopharma Reports Positive FDA Biosimilar Meeting Outcome

    GLOBENEWSWIRE

    iTeos to raise $120M; Xbrane and STADA to out-license Lucentis biosimilar

    ENDPTS

    AEON Receives Notice of Allowance for a Patent Covering Use of Botulinum Toxins

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.